Medulloblastoma; Mdb

Description

Medulloblastoma is the most common brain tumor in children. It accounts for 16% of all pediatric brain tumors, and 40% of all cerebellar tumors in childhood are medulloblastoma. Medulloblastoma occurs bimodally, with peak incidences between 3 and 4 years and 8 and 9 years of age. Approximately 10 to 15% of medulloblastomas are diagnosed in infancy. Medulloblastoma accounts for less than 1% of central nervous system (CNS) tumors in adults, with highest incidence in adults 20 to 34 years of age. In 1 to 2% of patients, medulloblastoma is associated with Gorlin syndrome (OMIM ), a nevoid basal carcinoma syndrome. Medulloblastoma also occurs in up to 40% of patients with Turcot syndrome (OMIM ). Medulloblastoma is thought to arise from neural stem cell precursors in the granular cell layer of the cerebellum. Standard treatment includes surgery, chemotherapy, and, depending on the age of the patient, radiation therapy (Crawford et al., 2007).

Clinical Features

Phenotypes and symptoms related to Medulloblastoma; Mdb

  • Milia
  • Neoplasm
  • Nevus
  • Basal cell carcinoma
  • Colon cancer
  • Brain neoplasm
  • Medulloblastoma
  • Cerebellar medulloblastoma

Incidence and onset information

Not enough data available about incidence and published cases.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Medulloblastoma; Mdb Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Syndromic Autism Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

NLGN3, NLGN4X, CTNNB1, UBE3C, ARID1B, TMEM231, TBR1, HOXA1, CHD8, AP1S2, CACNA1C, EHMT1, FOXP1, FOXP2, KIRREL3, LAMC3, MED12, MID1, NTNG1, ADNP , (...)

View the complete list with 63 more genes
Specificity
2 %
Genes
25 %
Rett-Angelman Syndrome 2nd-Tier Sequencing Panel.

By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center in United States.

CTNNB1, EHMT1, ZEB2, OPHN1, ATRX, CNTNAP2, TCF4, PNKP, NRXN1, PQBP1, MBD5, FOLR1, SLC2A1, PCDH19, MEF2C, FOXG1, CDKL5, ARX, SLC9A6, MECP2 , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
25 %
Non-Specific Intellectual Disability Panel.

By Genetic Services Laboratory University of Chicago in United States.

CA8, CC2D1A, CRBN, GRIK2, MAN1B1, PRSS12, TRAPPC9, ZC3H14, ZNF526, ZNF674, CDH15, SOBP, C12orf57, LINS1, LRP2, MED23, SLC25A1, KPTN, PACS1, VLDLR , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
25 %
Microcephaly Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

TUBGCP6, ASXL3, TUBGCP4, PYCR2, CRIPT, PLK4, ORC4, ORC6, CDT1, CDC6, ORC1, TRAPPC9, CEP63, KNL1, CEP135, ZNF335, CDK6, PHC1, CENPE, MFSD2A , (...)

View the complete list with 50 more genes
Specificity
2 %
Genes
25 %
Microcephaly Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

SLC1A4, PPP1R15B, USP18, TUBGCP6, ASXL3, TUBGCP4, PYCR2, CRIPT, PLK4, ORC4, ORC6, CDT1, CDC6, ORC1, NIN, TRAPPC9, CEP63, KNL1, CEP135, ZNF335 , (...)

View the complete list with 59 more genes
Specificity
2 %
Genes
25 %
CTNNB1. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

CTNNB1
Specificity
100 %
Genes
25 %
Colorectal cancer, somatic (sequence analysis of CTNNB1 gene).

By CGC Genetics in Portugal.

CTNNB1
Specificity
100 %
Genes
25 %
Comprehensive Vitreoretinopathy Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CAPN5, ATOH7, VCAN, RCBTB1, KIF11, ZNF408, CTNNB1, ISPD, FZD4, TSPAN12, NDP, ATP6V0A2, COL2A1, LRP5
Specificity
8 %
Genes
25 %
Comprehensive Inherited Retinal Dystrophies (includes RPGR ORF15) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

ACBD5, OR2W3, CFAP57, CEP250, SLC4A7, REEP6, NXNL1, MIR204, IFT81, PRDM13, IFT88, CAPN5, HMX1, ADAMTS18, RDH11, TUB, PCYT1A, RGS9BP, PLA2G5, VCAN , (...)

View the complete list with 285 more genes
Specificity
1 %
Genes
25 %
Non-syndromic Intellectual Disability (NS-ID) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DCPS, MYT1L, MED13L, TRIO, SIN3A, MAP3K7, ELP2, EXTL3, CIC, TBC1D23, TRAPPC6B, ABI2, CAPS, DMBT1, FBXO47, MAPK8, PIDD1, SDK2, SLAIN1, SPATA13 , (...)

View the complete list with 90 more genes
Specificity
1 %
Genes
25 %
Mental retardation - different panels.

By Institute of Human Genetics Cologne University in Germany.

EEF1B2, UBR7, PARP1, CAPN10, SLC31A1, TRMT1, PGAP2, GMPPA, TANGO2, IMPA1, RALGDS, ZBTB40, KCNK9, SETD1A, HERC2, TM4SF20, AHDC1, CCDC88A, ACBD6, KDM5A , (...)

View the complete list with 847 more genes
Specificity
1 %
Genes
25 %
Custom solid tumor gene sequencing panel.

By Molecular Diagnostics Laboratory University Health Network in Canada.

RAC1, RICTOR, EIF1AX, HOXD8, ERBB4, CDKN2B, ERBB2, DDB2, CCND1, XPC, KDR, ERCC5, PDGFRB, CDK6, AKT1, GNA11, PDGFRA, SF3B1, EGFR, GNAQ , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
25 %
Mental Retardation and Dysmorphology - panels.

By MGZ Medical Genetics Center in Germany.

GATAD2B, CUL7, SPECC1L, IRF6, CCNQ, ROR2, CCND2, HEPACAM, TBC1D7, KPTN, WNT5A, SRCAP, UBR1, C2CD3, TCTN3, NOTCH2, PACS1, EPG5, ERCC8, AKT1 , (...)

View the complete list with 323 more genes
Specificity
1 %
Genes
25 %
Syndromal Diseases - panels.

By MGZ Medical Genetics Center in Germany.

PACS1, EPG5, ERCC8, AKT1, AKT3, PIK3R2, INSR, IDH1, ALX1, GNAQ, PIK3CA, CPLANE1, KIF7, GNAS, TRIM37, EFTUD2, EFNB1, EP300, TBX5, SALL4 , (...)

View the complete list with 322 more genes
Specificity
1 %
Genes
25 %
Cancer Hotspot Panel.

By Centogene AG - the Rare Disease Company in Germany.

MYCL, ROS1, RPTOR, KIF5B, GNAI2, GNA13, EML4, BRD4, ARAF, NFE2L2, GNG2, KEAP1, NRG1, CCNE1, CD74, RICTOR, ERBB4, MYC, BCL6, SMO , (...)

View the complete list with 68 more genes
Specificity
3 %
Genes
50 %
Solid Tumor Panel.

By Centogene AG - the Rare Disease Company in Germany.

KMT2C, FGFR4, NTRK3, ROS1, AXL, SMO, ERBB2, DDR2, KDR, PDGFRB, PIK3R1, AKT1, GNA11, IDH1, PDGFRA, ABL1, JAK2, EGFR, GNAQ, PIK3CA , (...)

View the complete list with 42 more genes
Specificity
2 %
Genes
25 %
Colorectal cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

CTNNB1
Specificity
100 %
Genes
25 %
Ovarian cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

CTNNB1
Specificity
100 %
Genes
25 %
Hepatocellular carcinoma, somatic.

By Centogene AG - the Rare Disease Company in Germany.

CTNNB1
Specificity
100 %
Genes
25 %
AllNeuro panel.

By Centogene AG - the Rare Disease Company in Germany.

FCGR2B, TNF, ALOX5AP, PRKCH, TLR5, TIRAP, NOS2, XBP1, KCNK18, AANAT, SNIP1, EIF4E, ZBTB18, ADAM10, YAP1, ICAM1, SNX3, CISH, TAS2R38, FRG1 , (...)

View the complete list with 1185 more genes
Specificity
1 %
Genes
25 %
Colorectal cancer, somatic.

By Centogene AG - the Rare Disease Company in Germany.

CTNNB1
Specificity
100 %
Genes
25 %
Arrhythmogenic cardiomyopathy.

By Health in Code in Spain.

PPP1R13L, PERP, PKP4, CTNNA3, DSC2, JUP, DSG2, PLN, TGFB3, CASQ2, RYR2, PKP2, CTNNB1, SCN5A, TMEM43, LDB3, FLNC, DES, TTN, LMNA , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
25 %
Cardiovascular Diseases_General Panel.

By Health in Code in Spain.

CH25H, BMP10, TRIB1, TOPBP1, ISL1, GREM2, HAND2, SLC25A40, NNT, PPARA, MYOM1, LPA, SLC22A8, IRX3, KCNK17, PPP1R13L, PERP, FHOD3, FOXD4, SMAD1 , (...)

View the complete list with 360 more genes
Specificity
1 %
Genes
25 %
Arrhythmia General Panel.

By Health in Code in Spain.

GREM2, NNT, MYOM1, IRX3, KCNK17, PPP1R13L, PERP, FHOD3, FOXD4, NKX2-6, MRPL44, KCND2, COA6, TRIM63, KLF10, PKP4, TNNI3K, CALM3, CALR3, MIB1 , (...)

View the complete list with 198 more genes
Specificity
1 %
Genes
25 %
Cardiomyopathies General Panel.

By Health in Code in Spain.

NNT, MYOM1, PPP1R13L, PERP, FHOD3, FOXD4, MRPL44, COA6, TRIM63, KLF10, PKP4, TNNI3K, CALR3, MIB1, TBX20, CAVIN4, CHRM2, GATA5, CTNNA3, COA5 , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
25 %
Hereditary Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC, AIP , (...)

View the complete list with 92 more genes
Specificity
3 %
Genes
75 %
Intellectual Disability NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

AQP7, TPH2, AFP, XIST, SNIP1, ZBTB24, GLUL, DIP2B, KCNK9, UPB1, CEP57, FTO, ZBTB16, TMCO1, IRX5, AGT, IGF1R, MRAP, HDAC4, IGF1 , (...)

View the complete list with 372 more genes
Specificity
1 %
Genes
50 %
CTNNB1.

By Fulgent Genetics Fulgent Genetics in United States.

CTNNB1
Specificity
100 %
Genes
25 %
Hemato-oncology chromosomal microarray.

By Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center in United States.

NUTM2B, NUTM2A, SSX2, MALAT1, ETV4, TFEB, SSX4, NR4A3, MSI2, CREB3L2, TFE3, FOXO1, ETV1, ACSL3, RABEP1, SSX1, SS18, POU5F1, HEY1, JUN , (...)

View the complete list with 72 more genes
Specificity
5 %
Genes
100 %
Retinal Dystrophy Panel.

By Blueprint Genetics in Finland.

ARMC9, REEP6, IFT81, PRDM13, CAPN5, HMX1, ADAMTS18, RDH11, TUB, PCYT1A, RGS9BP, PLA2G5, ATOH7, VCAN, PEX11B, CEP78, SAMD11, ARHGEF18, CWC27, RTN4IP1 , (...)

View the complete list with 240 more genes
Specificity
1 %
Genes
25 %
Spastic Paraplegia Panel.

By Blueprint Genetics in Finland.

ATAD3A, DARS, RARS, IBA57, MARS2, COASY, AP4M1, AP4E1, AP4B1, AP4S1, DDHD1, DDHD2, CYP2U1, GBA2, B4GALNT1, C19orf12, HACE1, CAPN1, SLC16A2, CTNNB1 , (...)

View the complete list with 40 more genes
Specificity
2 %
Genes
25 %
Vitreoretinopathy Panel.

By Blueprint Genetics in Finland.

CAPN5, P3H2, ATOH7, VCAN, COL18A1, CTC1, KIF11, ZNF408, CTNNB1, COL11A2, COL11A1, COL9A2, COL9A3, COL9A1, NR2E3, FZD4, TSPAN12, RS1, KCNJ13, NDP , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
25 %
Focus::Oncomine™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

JAK1, ESR1, ROS1, ERBB4, SMO, ERBB2, DDR2, AKT1, GNA11, IDH1, PDGFRA, JAK2, EGFR, GNAQ, PIK3CA, JAK3, KIT, ERBB3, MTOR, CTNNB1 , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
25 %
Nephroblastoma.

By Bioarray in Spain.

CTNNB1
Specificity
100 %
Genes
25 %
Solid Tumor Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

BCL2L1, H3F3A, KLF4, TRAF7, PIK3C2B, HIST1H3B, JAK1, MCL1, PBRM1, DAXX, CDKN1A, MYB, MYBL1, RAD54B, ESR2, ESR1, KMT2C, FGFR4, ROS1, NFE2L2 , (...)

View the complete list with 102 more genes
Specificity
2 %
Genes
50 %
CNS Tumor Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

H3F3A, KLF4, TRAF7, HIST1H3B, DAXX, FUBP1, MYB, MYBL1, CIC, MYC, SMO, MN1, ERBB2, NTRK2, PIK3R1, AKT1, IDH1, PDGFRA, EGFR, PIK3CA , (...)

View the complete list with 28 more genes
Specificity
5 %
Genes
50 %
Melanoma Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

KMT2C, ROS1, RAC1, ERBB4, ERBB2, CCND1, PDGFRB, AKT1, GNA11, PDGFRA, EGFR, GNAQ, PIK3CA, BAP1, KIT, TERT, MTOR, CTNNB1, MED12, KMT2D , (...)

View the complete list with 18 more genes
Specificity
3 %
Genes
25 %
Gynecologic Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

ERBB4, PPP2R1A, FAT1, SMO, ERBB2, CDK12, CCND1, KDR, PIK3R1, AKT1, AKT3, PIK3R2, POLE, FBXW7, ABL1, EGFR, AKT2, POLD1, PIK3CA, JAK3 , (...)

View the complete list with 30 more genes
Specificity
4 %
Genes
50 %
FoundationOne® Heme.

By Foundation Medicine, Inc. in United States.

TRAF5, PIM1, PRDM1, HIST1H2AG, HIST1H3B, HIST1H1C, HDAC1, GTSE1, HIST1H1D, HIST1H2BK, HIST1H2BO, HIST1H2BC, HIST1H2AC, HIST1H2AM, HIST1H1E, HIST1H2AL, HDAC7, HIST1H2BJ, INPP5D, IKZF2 , (...)

View the complete list with 385 more genes
Specificity
1 %
Genes
75 %
Guardant360.

By Guardant Health in United States.

MAPK3, RHOA, RHEB, MAPK1, ESR1, NTRK3, ROS1, ARAF, NFE2L2, CCNE1, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, CCND2, AKT1, GNA11, FBXW7 , (...)

View the complete list with 53 more genes
Specificity
3 %
Genes
50 %
Comprehensive Panel for Individualized Cancer Threatment.

By GeneKor MSA in Greece.

ROS1, ERBB4, SMO, ERBB2, DDR2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA , (...)

View the complete list with 32 more genes
Specificity
2 %
Genes
25 %
Cancer Hotspot Analysis.

By Advanced Technology Laboratory Spectrum Health in United States.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 30 more genes
Specificity
2 %
Genes
25 %
Circulo Melanoma.

By Circulogene Theranostics in United States.

CTNNB1
Specificity
100 %
Genes
25 %
NeoTYPE® Discovery Profile for Solid Tumors.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

IKBKE, INPP4B, HSP90AA1, LRP1B, BCL2L2, AURKB, LMO1, ARFRP1, MDM4, MAP2K4, MCL1, EMSY, CHEK1, PBRM1, DAXX, PDCD1LG2, EPHB1, EPHA3, DOT1L, EPHA5 , (...)

View the complete list with 295 more genes
Specificity
1 %
Genes
75 %
Caris MI TumorSeek 592-Gene NGS Panel.

By Caris Life Sciences in United States.

ETV1, BCL3, SET, ELL, BTG1, ADGRA2, ACSL3, AFF1, ACSL6, ACKR3, RABEP1, PSIP1, RANBP17, RAD51B, RPL22, SDC4, SH3GL1, REL, SLC45A3, SYK , (...)

View the complete list with 571 more genes
Specificity
1 %
Genes
75 %
OmniSeq Comprehensive.

By OmniSeq, Inc. in United States.

NKX2-8, RHOA, BCL2L1, ETV4, ETV1, GAS6, RPS6KB1, RHEB, SPOP, TIAF1, XPO1, ZNF217, JAK1, KNSTRN, IFITM1, APEX1, ATP11B, MDM4, BCL9, BIRC2 , (...)

View the complete list with 124 more genes
Specificity
2 %
Genes
50 %
Solid Tumor Targeted Mutation and Fusion Panel.

By Providence Regional Laboratories Providence Health and Services in United States.

ETV1, JAK1, ERG, ESR1, FGFR4, NTRK3, ROS1, ERBB4, AXL, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, NTRK2, AKT1, AKT3, GNA11, IDH1 , (...)

View the complete list with 30 more genes
Specificity
2 %
Genes
25 %
Mental Retardation (Complete Panel) , Panel Massive Sequencing (NGS) 91 Genes.

By Reference Laboratory Genetics in Spain.

ZBTB18, HERC2, PPP2R1A, MYT1L, TRIO, POGZ, GNB1, CA8, CC2D1A, CRBN, GRIK2, MAN1B1, PRSS12, TRAPPC9, ZC3H14, CDH15, SOBP, LINS1, MED23, TECR , (...)

View the complete list with 71 more genes
Specificity
2 %
Genes
25 %
Autosomal Dominant Mental Retardation , Panel Massive Sequencing (NGS) 31 Genes.

By Reference Laboratory Genetics in Spain.

ZBTB18, PPP2R1A, MYT1L, TRIO, POGZ, GNB1, CDH15, CACNG2, EPB41L1, ZMYND11, DPP6, ARID1A, SMARCB1, SMARCA4, CTNNB1, ARID1B, EHMT1, KIRREL3, ADNP, SETBP1 , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
25 %
152 Integrated Advantage NGS Solid Tumor Panel.

By Integrated Molecular Diagnostics Pathology, Inc. in United States.

AURKA, TOP1, ABCC1, SLC29A1, STK11IP, SYK, SULT1A1, XRCC1, TOP2A, TOP2B, PLK1, JAK1, JUN, IKBKE, BCL2L2, AURKB, MDM4, MAP2K4, EMSY, CHEK1 , (...)

View the complete list with 132 more genes
Specificity
2 %
Genes
50 %
Tempus xT assay.

By Tempus Labs, Inc. in United States.

HLA-DRB5, HLA-C, PPP6C, ZNRF3, FOXQ1, TBC1D12, WEE1, YEATS4, POU2F2, C8orf34, SEMA3C, PDPK1, HLA-G, LAG3, CCDC6, MEF2B, AURKA, TOP1, P2RY8, FGF4 , (...)

View the complete list with 571 more genes
Specificity
1 %
Genes
100 %
Tempus xO assay.

By Tempus Labs, Inc. in United States.

SETD6, PIM3, MAP3K10, PDGFA, MAP3K11, PAK2, KHSRP, WASL, CASC11, GLIS1, NRG2, SOX21, SMARCC1, CUL4A, UTY, WNT9A, TEF, CHIC1, TRIM28, CDK11B , (...)

View the complete list with 1693 more genes
Specificity
1 %
Genes
100 %
CEN4GEN Colorectal cancer: Extended Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MIER3, TCERG1, ATP6V0D2, ACVR1B, PTPN12, GALNT17, MAP2K4, MAP7, FZD3, MYO1B, CDC27, TCF7L2, BAX, DCC, ERBB2, MSH3, GPC6, PIK3R1, AKT1, FBXW7 , (...)

View the complete list with 18 more genes
Specificity
3 %
Genes
25 %
CEN4GEN Gastric cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WNK2, ADGRB3, SSTR1, TRRAP, LRP1B, LPAR2, GPR78, ATP4A, CCNE1, TRIO, DCC, MYC, ERBB2, PRKDC, FBXW7, PIK3CA, SPEG, NOTCH1, CTNNB1, S1PR2 , (...)

View the complete list with 9 more genes
Specificity
7 %
Genes
50 %
CEN4GEN Ovarian cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

KREMEN1, USP16, MAS1L, CSMD3, FAT3, GABRA6, CCNE1, PPP2R1A, ERBB2, CDK12, PIK3R1, AKT1, CBLC, PDGFRA, EGFR, PIK3CA, KIT, ARID1A, CTNNB1, NF1 , (...)

View the complete list with 12 more genes
Specificity
7 %
Genes
50 %
CEN4GEN Comprehensive Solid tumors (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ESR1, SMO, ERBB2, AKT1, IDH1, PDGFRA, EGFR, PIK3CA, KIT, MTOR, CTNNB1, MET, CDKN2A, STK11, PTCH1, ATM, MAP2K2, FGFR2, NRAS, KRAS , (...)

View the complete list with 12 more genes
Specificity
7 %
Genes
50 %
CEN4GEN Comprehensive targeted oncogene tumor mutation screen (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
25 %
BRCA2.

By Molecular Diagnostic Laboratory Kingston General Hospital in Canada.

BRCA2
Specificity
100 %
Genes
25 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis.

By Baylor Miraca Genetics Laboratories in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
BRCA1 & BRCA2 Seq and Del/Dup Analysis.

By Baylor Miraca Genetics Laboratories in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary High Risk Breast Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Hereditary Melanoma Panel.

By Baylor Miraca Genetics Laboratories in United States.

CDKN2A, CDK4, TP53, BRCA2
Specificity
25 %
Genes
25 %
Hereditary Prostate Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

CHEK2, NBN, TP53, BRCA2, BRCA1
Specificity
20 %
Genes
25 %
Hereditary Pancreatic Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD50, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Hereditary Leukemia/Lymphoma Panel.

By Baylor Miraca Genetics Laboratories in United States.

PRF1, CEBPA, SBDS, PAX5, GATA2, BRIP1, PALB2, ATM, CBL, PTPN11, TP53, RUNX1, BRCA2
Specificity
8 %
Genes
25 %
Comprehensive Hereditary Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD51D, PMS1, ENG, BARD1, RAD51C, CDC73, PRKAR1A, PRF1, CEBPA, SBDS, PAX5, GATA2, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET , (...)

View the complete list with 41 more genes
Specificity
4 %
Genes
50 %
Hereditary Colorectal/Gastrointestinal Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

PMS1, ENG, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
25 %
Breast-ovarian cancer, familial 2 (BRCA2).

By Center for Human Genetics, Inc in United States.

BRCA2
Specificity
100 %
Genes
25 %
Breast & Ovarian Cancer, Familial (BRCA1 & BRCA2).

By Center for Human Genetics, Inc in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Comprehensive breast and ovarian cancer panel testing (18 genes).

By Molecular Genetics Laboratory North York General Hospital in Canada.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Comprehensive breast cancer panel testing (10 genes).

By Molecular Genetics Laboratory North York General Hospital in Canada.

BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
BRCA1 and BRCA2 sequencing and deleetion/duplication analysis.

By Molecular Genetics Laboratory North York General Hospital in Canada.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary breast and ovarian cancer - full panel.

By CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario in Canada.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary breast and ovarian cancer - familial variant analysis.

By CHEO Genetics Diagnostic Laboratory Children's Hospital of Eastern Ontario in Canada.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast Cancer Predisposition, (BRCA1, BRCA2, TP53, CHEK2, PALB2, CDH1, PTEN, STK11, ATM), Mutation, Deletion/Duplication Analysis.

By Clinical Molecular Diagnostic Laboratory City of Hope National Medical Center in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Fanconi Anemia Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
25 %
Inherited Cancer Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

CDKN1B, BAP1, XRCC2, MITF, NF1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, CDKN2A, CDK4 , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
25 %
Bone Marrow Failure.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RPL36, USB1, RPS7, RPS15, THPO, RPS27A, SRP72, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, NOP10, NHP2 , (...)

View the complete list with 23 more genes
Specificity
3 %
Genes
25 %
Inherited Breast Cancer.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

CHEK2, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Inherited Ovarian Cancer.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
BRCA1/2 Ashkenazi Jewish Profile (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1/2 Comprehensive Analysis (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1/2 Deletion/Duplication Analysis (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2 Targeted Analysis (BRCAssure).

By Molecular Diagnostic Laboratory LabCorp in United States.

BRCA2
Specificity
100 %
Genes
25 %
VistaSeq Hereditary Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
25 %
VisaSeq Breast and GYN Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
VistaSeq Breast Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

ABRAXAS1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
VistaSeq High/Moderate Risk Breast Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
12 %
Genes
25 %
VistaSeq Pancreatic Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
VistaSeq Colorectal Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

AXIN2, POLE, POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
25 %
VistaSeq GYN Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
myRisk Hereditary Cancer.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
25 %
BRCA2 Gene Analysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2 Single Mutation Analysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2
Specificity
100 %
Genes
25 %
PANEXIA.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

PALB2, BRCA2
Specificity
50 %
Genes
25 %
Integrated BRACAnalysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
MultiSite 3 BRACAnalysis.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRACAnalysis CDx™.

By Myriad Genetic Laboratories, Inc. Myriad Genetic Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Bone Marrow Failure Syndromes Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, RAB27A, USB1, RPS7, SRP72, ERCC4, FANCD2, FANCI, FANCL, FANCM , (...)

View the complete list with 39 more genes
Specificity
2 %
Genes
25 %
Fanconi Anemia Panel by next-generation sequencing (NGS).

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

ERCC4, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
25 %
Bone Marrow Failure Syndromes Deletion/Duplication Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, RPL26, VPS45, G6PC3, ELANE, CSF3R, RAB27A, USB1, RPS7, SRP72, ERCC4, FANCI, FANCL, FANCM, SLX4, FANCE , (...)

View the complete list with 35 more genes
Specificity
2 %
Genes
25 %
Fanconi Anemia Deletion/Duplication Panel.

By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center in United States.

ERCC4, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
25 %
Tier 2: Hereditary Lymphoma and Immunodeficiency Panel.

By Genetic Services Laboratory University of Chicago in United States.

CARD11, CTLA4, CD27, PIK3CD, ITK, STXBP2, CASP10, FASLG, FAS, TNFRSF13B, IKZF1, SH2D1A, DOCK8, MAGT1, NF1, WAS, PRF1, NBN, ATM, BLM , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
25 %
Inherited Bone Marrow Failure Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

SAMD9L, SAMD9, NAF1, POT1, DNAJC21, ACD, CXCR4, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, USB1, RPS7, SRP72, ERCC4, XRCC2 , (...)

View the complete list with 41 more genes
Specificity
2 %
Genes
25 %
Tier 2: Familial Myelodysplastic Syndrome/Acute Leukemia (MDS/AL) Panel.

By Genetic Services Laboratory University of Chicago in United States.

NF1, CHEK2, ATM, CBL, PTPN11, BLM, TP53, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Hereditary Gastric Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

PDGFRA, KIT, CTNNA1, SMAD4, BMPR1A, STK11, CDH1, SDHB, SDHC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Familial BRCA1 and BRCA2 mutation analysis.

By Genetic Services Laboratory University of Chicago in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
3 Ashkenazi BRCA1 and BRCA2 mutation analysis.

By Genetic Services Laboratory University of Chicago in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Comprehensive Hereditary Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, POLE, ETV6, IKZF1, POLD1, SRP72, BAP1, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, BRIP1, SMAD4, BMPR1A, MAX , (...)

View the complete list with 34 more genes
Specificity
2 %
Genes
25 %
Hereditary Leukemia and Breast Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, ETV6, IKZF1, SRP72, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, CHEK2, CDH1, PALB2, NBN, ATM, CBL, PTPN11 , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
25 %
Hereditary Melanoma Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

WRN, POT1, ACD, POLE, BAP1, CDKN2A, CDK4, MC1R, TP53, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Fanconi Anemia Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

UBE2T, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
25 %
Hereditary Myeloid Malignancy and Inherited Bone Marrow Failure Panel.

By Genetic Services Laboratory University of Chicago in United States.

RAD51, UBE2T, SAMD9L, SAMD9, NAF1, POT1, DNAJC21, ACD, CXCR4, GFI1, RBM8A, RPL26, VPS45, G6PC3, RPL15, ELANE, CSF3R, ETV6, IKZF1, USB1 , (...)

View the complete list with 59 more genes
Specificity
2 %
Genes
25 %
Hereditary Breast and Ovarian Cancer High Risk Panel.

By Genetic Services Laboratory University of Chicago in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
BRCA1 and BRCA2 Mutation Analysis.

By Genetic Services Laboratory University of Chicago in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1, BRCA2, and PALB2 Mutation Analysis.

By Genetic Services Laboratory University of Chicago in United States.

PALB2, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
BRCA1, BRCA2, and TP53 Mutation Analysis.

By Genetic Services Laboratory University of Chicago in United States.

TP53, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
Comprehensive Hereditary Breast/Ovarian Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Comprehensive BRCA1/BRCA2 Testing.

By United States Air Force Molecular Diagnostic Laboratory United States Air Force in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Molecular Genetics Rabin Medical Center in Israel.

BRCA2
Specificity
100 %
Genes
25 %
Breast Cancer BRCA2.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Panel.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Breast and Ovarian Cancer.

By Institute of Human Genetics Universitätsmedizin Greifswald in Germany.

RAD51C, CHEK2, PALB2, BRCA2, BRCA1
Specificity
20 %
Genes
25 %
BRCA2.

By Institute for Human Genetics University Clinic Freiburg in Germany.

BRCA2
Specificity
100 %
Genes
25 %
Breast Cancer-Predisposition Genes.

By Service de Génétique Gustave Roussy in France.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2-Hereditary Cancer of the Breast.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary Cancer Panel Comprehensive.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

POLE, GREM1, POLD1, CTNNA1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, SDHB, TP53 , (...)

View the complete list with 10 more genes
Specificity
4 %
Genes
25 %
Hereditary Cancer Panel - High Penetrance 16.

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Breast and Ovarian Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 20 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, MEN1, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, BRCA2, BRCA1
Specificity
5 %
Genes
25 %
Cancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

CDKN1B, BAP1, SMARCB1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1, SUFU, PALB2 , (...)

View the complete list with 27 more genes
Specificity
5 %
Genes
50 %
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Sequencing and Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA 2) Sequencing.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and Ovarian Hereditary Cancer Syndrome (BRCA1 and BRCA2) Deletion/Duplication.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Comprehensive Cancer Panel.

By GeneDx in United States.

AXIN2, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
25 %
Breast Cancer High Risk Panel and PALB2.

By GeneDx in United States.

CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
17 %
Genes
25 %
Breast Cancer High/Moderate Risk Panel.

By GeneDx in United States.

CHEK2, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
13 %
Genes
25 %
Oncology High/Moderate Risk Panel.

By GeneDx in United States.

RAD51D, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, APC , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
25 %
Breast Cancer High Risk Panel.

By GeneDx in United States.

CDH1, TP53, PTEN, BRCA2, BRCA1
Specificity
20 %
Genes
25 %
Breast/Ovarian Cancer Panel.

By GeneDx in United States.

XRCC2, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
5 %
Genes
25 %
Pancreatic Cancer Panel.

By GeneDx in United States.

XRCC2, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Endometrial Cancer Panel.

By GeneDx in United States.

POLD1, CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
9 %
Genes
25 %
OncoGeneDx Custom Panel.

By GeneDx in United States.

AXIN2, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
25 %
BRCA1/2 Sequencing and Del/Dup Analysis.

By GeneDx in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1 and BRCA2 Sequencing.

By GeneDx in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1 and BRCA2 Del/Dup.

By GeneDx in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Cancer Panel - Breast9.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
12 %
Genes
25 %
Hereditary Cancer Panel - Breast/Ovarian/Uterine26.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

ABRAXAS1, XRCC2, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
25 %
Hereditary Cancer Panel - Pancreatic14.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Hereditary Cancer Panel - Breast/Ovarian17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer.

By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust in United Kingdom.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA Ashkenazi Jewish 3-mutation panel.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA Ashkenazi Jewish 3-mutation panel reflext to BRCA1/2 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA Portuguese 1-mutation panel specific site analysis.

By Ambry Genetics in United States.

BRCA2
Specificity
100 %
Genes
25 %
BRCAplus.

By Ambry Genetics in United States.

CHEK2, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
13 %
Genes
25 %
BRCA1 and BRCA2 gene sequence and deletion/duplication.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BreastNext.

By Ambry Genetics in United States.

NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
CancerNext-Expanded.

By Ambry Genetics in United States.

HOXB13, GALNT12, DICER1, POT1, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1 , (...)

View the complete list with 44 more genes
Specificity
4 %
Genes
50 %
CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
25 %
CustomNext: Cancer.

By Ambry Genetics in United States.

NTHL1, HOXB13, GALNT12, DICER1, POT1, AIP, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C , (...)

View the complete list with 48 more genes
Specificity
3 %
Genes
50 %
MelanomaNext.

By Ambry Genetics in United States.

BAP1, MITF, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
13 %
Genes
25 %
OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
ProstateNext.

By Ambry Genetics in United States.

HOXB13, RAD51D, CHEK2, PALB2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
PancNext.

By Ambry Genetics in United States.

CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
TumorNext-BRCA.

By Ambry Genetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
TumorNext-HRD+CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
25 %
TumorNext-Lynch+CancerNext.

By Ambry Genetics in United States.

HOXB13, DICER1, POLE, GREM1, POLD1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
TumorNext-HRD+OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
TumorNext-HRD.

By Ambry Genetics in United States.

RAD51D, BARD1, RAD51C, BRIP1, CHEK2, PALB2, NBN, MRE11, ATM, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
TumorNext-Lynch+OvaNext.

By Ambry Genetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, NRAS, KRAS, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
25 %
GYNplus.

By Ambry Genetics in United States.

RAD51D, RAD51C, BRIP1, PALB2, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
BRCA2. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2
Specificity
100 %
Genes
25 %
BRCA1, BRCA2. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1, BRCA2. NextGeneDx.Complete sequencing by NGS.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2. MLPA testing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary Breast, Ovarian, and Endometrial Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

WRN, ITK, FANCA, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, MEN1, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
25 %
Hereditary High-Risk Breast Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Hereditary Colorectal and Gastrointestinal Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

POLE, POLD1, KIT, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
25 %
Hereditary Melanoma Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

WRN, BAP1, TERT, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
CHOP Comprehensive Hereditary Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

DDB2, DIS3L2, MTAP, CEBPE, POLH, ARID5B, HMBS, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, DDX41, COL7A1, G6PC3, ITK, ELANE, EXT1, EXT2 , (...)

View the complete list with 86 more genes
Specificity
1 %
Genes
25 %
Hereditary Pancreatic Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

PRSS1, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Hereditary Prostate Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

CHEK2, NBN, TP53, BRCA2, BRCA1
Specificity
20 %
Genes
25 %
Familial breast/ovarian cancer (deletion/duplication analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
25 %
Fanconi anemia (NGS panel for 15 genes).

By CGC Genetics in Portugal.

FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
25 %
Breast cancer (NGS panel for 10 genes).

By CGC Genetics in Portugal.

RAD51D, RAD51C, BRIP1, CHEK2, CDH1, PALB2, ATM, TP53, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Breast cancer (NGS panel for 18 genes).

By CGC Genetics in Portugal.

ERCC4, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Pancreatic familial carcinoma (sequence analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Pancreatic cancer (NGS panel for 3 genes).

By CGC Genetics in Portugal.

PALB2, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
Familial breast/ovarian cancer (deletion/duplication analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Familial breast/ovarian cancer (sequence analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Familial breast/ovarian cancer (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
25 %
Breast cancer (mutations 187delAG(BRCA1), 5385insC(BRCA1), 6174delT(BRCA2)).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
OncoRisk (NGS panel for 48 genes).

By CGC Genetics in Portugal.

EXT1, EXT2, FANCA, FANCB, NF1, RAD51C, CDC73, PRKAR1A, CEBPA, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN1C, CDKN2A, CDK4 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
25 %
OncoRisk Plus (NGS panel for 89 genes).

By CGC Genetics in Portugal.

CEP57, DDB2, DIS3L2, XPC, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
3 %
Genes
50 %
Familial breast/ovarian cancer (deletion/duplication analysis and sequence analysis of BRCA1 and BRCA2 genes).

By CGC Genetics in Portugal.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Familial pancreatic carcinoma (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
25 %
Prostate cancer (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
25 %
Familial pancreatic carcinoma (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
25 %
Prostate cancer (sequence analysis of BRCA2 gene).

By CGC Genetics in Portugal.

BRCA2
Specificity
100 %
Genes
25 %
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer Test.

By Laboratory of Genetics HUSLAB in Finland.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1 and BRCA2 Finnish founder mutations.

By Laboratory of Genetics HUSLAB in Finland.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Ovarian Cancer.

By Laboratory of Genetics HUSLAB in Finland.

RAD51, RAD51D, BARD1, RAD51C, BRIP1, RAD50, NBN, MRE11, TP53, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Fanconi Anemia via BRCA2/FANCD1 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary Breast and Ovarian Cancer BRCA1/2 Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, RET, TP53 , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
25 %
Fanconi Anemia Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

MAD2L2, RAD51, UBE2T, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2 , (...)

View the complete list with 1 more genes
Specificity
5 %
Genes
25 %
Pancreatic Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

PALLD, CDKN2A, CDK4, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Congenital Limb Malformation Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

LMBR1, NOG, FMN1, FBXW4, FBLN1, IHH, WNT3, BMP2, TBX3, HDAC4, GDF5, DOCK6, ARHGAP31, HOXD13, SF3B4, LRP4, WNT7A, TBX15, ROR2, ESCO2 , (...)

View the complete list with 49 more genes
Specificity
2 %
Genes
25 %
Breast Cancer - Comprehensive Risk Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

RECQL, NF1, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Breast Cancer - High Risk Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
17 %
Genes
25 %
Hereditary Endometrial Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLD1, CHEK2, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
9 %
Genes
25 %
Breast Cancer - High / Moderate Risk Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
12 %
Genes
25 %
Hereditary Ovarian Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DICER1, XRCC2, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, FANCC, TP53, PTEN, MUTYH , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
25 %
Prostate Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

HOXB13, RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Melanoma Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POT1, BAP1, MITF, CHEK2, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
10 %
Genes
25 %
Comprehensive BRCA1 and BRCA2 seqeuncing, tumor specimens.

By Molecular Diagnostics Laboratory University Health Network in Canada.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast Cancer – Basic Diagnostics.

By MGZ Medical Genetics Center in Germany.

RAD51D, RAD51C, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
BRCA.

By MGZ Medical Genetics Center in Germany.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By MGZ Medical Genetics Center in Germany.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary Cancer Syndromes - panels.

By MGZ Medical Genetics Center in Germany.

RNF43, CEP57, DDB2, DIS3L2, XPC, NTHL1, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, AXIN2, POLE, EGFR, GREM1 , (...)

View the complete list with 80 more genes
Specificity
2 %
Genes
50 %
Ovarian Cancer.

By MGZ Medical Genetics Center in Germany.

CEP57, BUB1B, DICER1, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, ATM, FANCC , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
25 %
Ovarian Cancer – Basic Diagnostics.

By MGZ Medical Genetics Center in Germany.

RAD51D, RAD51C, BRIP1, CHEK2, PALB2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Breast Cancer.

By MGZ Medical Genetics Center in Germany.

CEP57, BUB1B, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, NF1, RAD51D, RAD51C, BRIP1, CHEK2, SDHD, STK11, CDH1 , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
Pancreatic Cancer.

By MGZ Medical Genetics Center in Germany.

PMS1, CHEK2, CDKN2A, STK11, PALB2, PTEN, MLH1, MSH6, PMS2, MSH2, BRCA2
Specificity
10 %
Genes
25 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Bioscientia GmbH Center for Human Genetics in Germany.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Bioscientia GmbH Center for Human Genetics in Germany.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2.

By GeneTech ATS GeneTech Private Limited in India.

BRCA2
Specificity
100 %
Genes
25 %
Breast cancer panel.

By Genome Diagnostics Laboratory University Medical Center Utrecht in Netherlands.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
CentoBreast (hereditary breast cancer) panel.

By Centogene AG - the Rare Disease Company in Germany.

BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Prostate cancer panel.

By Centogene AG - the Rare Disease Company in Germany.

HOXB13, CHEK2, NBN, TP53, PTEN, MLH1, MSH6, MSH2, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
CentoICU platinum plus.

By Centogene AG - the Rare Disease Company in Germany.

OPLAH, PPM1K, IKBKB, LCK, CABS1, SOX6, OPRM1, IL2, CTPS1, IRF8, CD247, ADK, UQCC2, MPC1, UPB1, CORO1A, CD3G, MCM4, UQCRC2, GPHN , (...)

View the complete list with 494 more genes
Specificity
1 %
Genes
25 %
CentoICU platinum.

By Centogene AG - the Rare Disease Company in Germany.

FRAS1, TSPYL1, IL2RA, CARD11, NOTCH2, TNFRSF13C, PRKDC, ICOS, CD81, CR2, CD19, F7, JAGN1, ABCC2, NFKB2, IL12RB1, COL7A1, COL17A1, ITGA6, ITGB4 , (...)

View the complete list with 494 more genes
Specificity
1 %
Genes
25 %
Prostate cancer.

By Centogene AG - the Rare Disease Company in Germany.

BRCA2
Specificity
100 %
Genes
25 %
CentoCancer panel.

By Centogene AG - the Rare Disease Company in Germany.

NTHL1, POLE, POLD1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, FLCN, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, BLM, FH , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
25 %
Breast cancer.

By Centogene AG - the Rare Disease Company in Germany.

BRCA2
Specificity
100 %
Genes
25 %
Fanconi anemia type D1.

By Centogene AG - the Rare Disease Company in Germany.

BRCA2
Specificity
100 %
Genes
25 %
BRCA Ashkenazi Jewish 3 founder mutation testing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1 and BRCA2 mutation panel.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2 deletion/duplication testing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2 Gene Sequencing.

By Michigan Medical Genetics Laboratories University of Michigan in United States.

BRCA2
Specificity
100 %
Genes
25 %
BRCA1 y BRCA2 Perfil Colombia.

By Instituto de Referencia Andino in Colombia.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Breast and Ovarian Cancer 2.

By Medical Genetics Laboratory Diagenom GmbH in Germany.

BRCA2
Specificity
100 %
Genes
25 %
BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2 mutations.

By Medical Genetics Institute Shaare Zedek Medical Center in Israel.

BRCA2
Specificity
100 %
Genes
25 %
Pancreatic cancer Panel.

By CeGaT GmbH in Germany.

PALLD, PRSS1, SPINK1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Fanconi anemia Panel.

By CeGaT GmbH in Germany.

FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Breast and Ovarian Cancer - extended Diagnostic Panel.

By CeGaT GmbH in Germany.

UIMC1, RINT1, MSH3, ABRAXAS1, XRCC2, FANCD2, SLX4, FANCE, FANCF, FANCG, FANCA, NF1, RAD51D, PMS1, BARD1, RAD51C, BRIP1, RAD50, CHEK2, SDHD , (...)

View the complete list with 21 more genes
Specificity
3 %
Genes
25 %
Prostate Cancer Panel.

By CeGaT GmbH in Germany.

CD82, MXI1, MSR1, BTNL2, HOXB13, CHEK2, CDH1, AR, ZFHX3, RNASEL, ELAC2, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Breast and Ovarian Cancer Panel.

By CeGaT GmbH in Germany.

RAD51D, RAD51C, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Bone marrow failure syndromes Panel.

By CeGaT GmbH in Germany.

IFNG, LIG4, STXBP2, STX11, SRP72, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, NOP10, NHP2, WRAP53, CTC1, CSF2RA , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
Test for BRCA2 Hereditary Breast and Ovarian Cancer.

By All Wales Genetics Laboratory Institute of Medical Genetics in United Kingdom.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary breast/ovarian cancer - analysis the BRCA2 gene mutations in accordance with EMQN recommendations.

By Laboratory of Human Genetics GENOMED Health Care Center in Poland.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2.

By Innovagenomics Innovagenomics S.L in Spain.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By GGA - Galil Genetic Analysis in Israel.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2.

By ProntoLab - MLPA Lab Pronto Diagnostics Ltd. in Israel.

BRCA2
Specificity
100 %
Genes
25 %
Breast and Ovarian Cancer.

By Asper Biogene Asper Biogene LLC in Estonia.

CHD1, RAD51, XRCC2, FANCD2, FANCE, FANCF, FANCG, FANCA, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, PALB2, NBN, MRE11, ATM, KRAS, FANCC , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
25 %
Ashkenazi Jewish diseases.

By Asper Biogene Asper Biogene LLC in Estonia.

F11, MEFV, CYP21A2, LRRK2, TOR1A, TMEM216, ABCC8, MCOLN1, SERPINA1, NEB, FKTN, SMN1, LDLR, GJB2, BLM, GBA, FANCC, CFTR, ELP1, ASPA , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
Cancer Predisposition.

By Asper Biogene Asper Biogene LLC in Estonia.

DDB2, DIS3L2, XPC, RHBDF2, CYLD, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
3 %
Genes
50 %
Fanconi Anemia.

By Asper Biogene Asper Biogene LLC in Estonia.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
25 %
BRCA2 sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Clinical Genomics Maastricht University Medical Centre in Netherlands.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, TP53, PALB2, CHEK2).

By Center for Human Genetics Cliniques Universitaires Saint Luc in Belgium.

CHEK2, PALB2, TP53, BRCA2, BRCA1
Specificity
20 %
Genes
25 %
BRCA2 Deletion Duplication (MLPA).

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

BRCA2
Specificity
100 %
Genes
25 %
BRCA2 Gene Sequencing.

By Advanced Molecular Diagnostics Mount Sinai Hospital in Canada.

BRCA2
Specificity
100 %
Genes
25 %
Breast-Ovarian cancer, familial 2.

By Praxis fuer Humangenetik Wien in Austria.

BRCA2
Specificity
100 %
Genes
25 %
BRCA 1 and BRCA2 Gene Sequencing.

By GENETIX Centro de Investigación en Genética Humana y Reproductiva in Colombia.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1 and BRCA2 deletion/duplication analysis.

By GENETIX Centro de Investigación en Genética Humana y Reproductiva in Colombia.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2 Hereditary Breast and Ovarian Cancer.

By Department of Clinical Genetics St. Elisabeth Cancer Institute in Slovakia.

BRCA2
Specificity
100 %
Genes
25 %
Inherited Cancer Screen.

By Counsyl in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, SDHA , (...)

View the complete list with 16 more genes
Specificity
3 %
Genes
25 %
qCancer Risk.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53 , (...)

View the complete list with 10 more genes
Specificity
4 %
Genes
25 %
qCancer Risk Expanded.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, MITF, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
25 %
qCancer BRCAs.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
qCancer Mama.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
12 %
Genes
25 %
qCancer Gine.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
5 %
Genes
25 %
Breast-Ovarian cancer, familial 2.

By MedGene in Slovakia.

BRCA2
Specificity
100 %
Genes
25 %
Invitae Breast Cancer Panel.

By Invitae in United States.

NF1, BARD1, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Invitae Common Hereditary Cancers Panel (Breast, Gyn, GI).

By Invitae in United States.

DICER1, AXIN2, POLE, PDGFRA, GREM1, POLD1, KIT, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, STK11 , (...)

View the complete list with 22 more genes
Specificity
3 %
Genes
25 %
Invitae Multi-Cancer Panel.

By Invitae in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, KIT, SMARCB1, SMARCA4, SMARCE1, TERT, TERC, MITF , (...)

View the complete list with 60 more genes
Specificity
3 %
Genes
50 %
Invitae Breast Cancer Guidelines-Based Panel.

By Invitae in United States.

NF1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Invitae Prostate Cancer Panel.

By Invitae in United States.

HOXB13, CHEK2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
9 %
Genes
25 %
Invitae Melanoma Panel.

By Invitae in United States.

POT1, BAP1, MITF, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
12 %
Genes
25 %
Invitae Breast and Gyn Cancers Guidelines-Based Panel.

By Invitae in United States.

NF1, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Invitae Bone Marrow Failure Syndromes Panel.

By Invitae in United States.

RPL26, ELANE, RPS7, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, NOP10, NHP2, CTC1, TERT, TERC, DKC1 , (...)

View the complete list with 19 more genes
Specificity
3 %
Genes
25 %
Invitae Breast Cancer STAT Panel.

By Invitae in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Invitae Pancreatic Cancer Panel.

By Invitae in United States.

NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
5 %
Genes
25 %
Invitae Hereditary Breast and Ovarian Cancer Syndrome Panel.

By Invitae in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Invitae Breast and Gyn Cancers Panel.

By Invitae in United States.

DICER1, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 3 more genes
Specificity
5 %
Genes
25 %
Invitae Fanconi Anemia Panel.

By Invitae in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
25 %
Invitae BRCA1 and BRCA2 STAT Panel.

By Invitae in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and ovarian cancer, Hereditary- BRCA1 and BRCA2 genes sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and ovarian cancer, Hereditary: BRCA1 and BRCA2 genes deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and ovarian cancer, Hereditary: BRCA1 and BRCA2 genes screening (22 founder mutations in Spanish families).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and ovarian cancer, Hereditary: BRCA2 gene deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Breast and ovarian cancer, Hereditary: BRCA2 gene screening (founder mutations in Spanish families).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Breast and ovarian cancer, Hereditary: BRCA2 gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Breast and ovarian cancer, Hereditary: BRCA2 gene sequence analysis and deletions-duplications analysis (MLPA).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Fanconi anemia.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
25 %
ONCOLOGY, PANEL.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

POLH, XPC, HOXB13, XPA, ERCC5, AIP, ELANE, PDGFRA, GREM1, ERCC4, CDKN1B, XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA , (...)

View the complete list with 60 more genes
Specificity
2 %
Genes
25 %
COLON, BREAST AND OVARIAN CANCER.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

MLH3, AXIN2, XRCC2, NF1, RAD51D, PMS1, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, KRAS , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
25 %
BRCA - breast cancer, familial.

By Genome Diagnostics VU University Medical Center in Netherlands.

CHEK2, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
BRCA - pancreatic cancer.

By Genome Diagnostics VU University Medical Center in Netherlands.

PALB2, BRCA2, BRCA1
Specificity
34 %
Genes
25 %
BRCA - ovarian cancer, familial.

By Genome Diagnostics VU University Medical Center in Netherlands.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Cancer Syndrome: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
4 %
Genes
50 %
High Risk Breast Cancer: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

XRCC2, SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
5 %
Genes
25 %
Pancreatic Cancer: Sequencing Panel and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BAP1, PRSS1, SMAD4, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Gastrointestinal and Colorectal Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Medical EmExome Array: Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2
Specificity
100 %
Genes
25 %
Ashkenazi Jewish: BRCA Targeted Mutation Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Gastrointestinal and Colorectal Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Cancer Syndrome: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
4 %
Genes
50 %
BRCA1 and BRCA2 genes sequence analysis: Hereditary Breast and Ovarian Cancer.

By DLE - Diagnosticos Laboratoriais Especializados in Brazil.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Fanconi Anemia NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ERCC4, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
25 %
Pancreatic Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BAP1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Melanoma NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

WRN, TERT, MITF, ERCC3, CDKN2A, CDK4, TYR, MC1R, RB1, TP53, PTEN, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
BRCA1 and BRCA2 Full Gene Sequencing.

By Fulgent Genetics Fulgent Genetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1 and BRCA2 Deletion/Duplication Analysis.

By Fulgent Genetics Fulgent Genetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2.

By Fulgent Genetics Fulgent Genetics in United States.

BRCA2
Specificity
100 %
Genes
25 %
Focus Cancer Panel - 40 Genes.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51, AXIN2, POLE, BAP1, KIT, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 20 more genes
Specificity
3 %
Genes
25 %
Breast Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BARD1, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Endometrial Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

POLD1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Ovarian Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51D, BARD1, RAD51C, BRIP1, STK11, NBN, MRE11, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Prostate Cancer Focus Panel.

By Fulgent Genetics Fulgent Genetics in United States.

CHEK2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Melanoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

BAP1, MITF, CHEK2, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
12 %
Genes
25 %
Pancreatic Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

NF1, SMAD4, BMPR1A, CDKN2A, CDK4, STK11, PALB2, ATM, TSC1, TSC2, FANCC, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
25 %
Comprehensive Cancer Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, DIS3L2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC , (...)

View the complete list with 104 more genes
Specificity
2 %
Genes
50 %
Breast Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

XRCC2, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Fanconi Anemia Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
25 %
Endometrial Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

POLD1, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Ovarian Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, STK11, NBN, MRE11, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Prostate Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

HOXB13, CHEK2, NBN, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
BRCAvantage, Ashkenazi Jewish Screen.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCAvantage, Rearrangements.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCAvantage, Comprehensive.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
MyVantage(TM) Hereditary Comprehensive Cancer Panel.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, SDHB , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
25 %
BREASTON.

By PentaCoreLab in Hungary.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BREASTON-EXTENDED.

By PentaCoreLab in Hungary.

DIRAS3, ERBB2, RAD51, BARD1, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, ATM, KRAS, TP53, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Fanconi Anemia Panel.

By Blueprint Genetics in Finland.

CXCR4, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, ATR, FANCB, RAD51C, BRIP1, PALB2, NBN, ATM, BLM , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
25 %
Hereditary Leukemia Panel.

By Blueprint Genetics in Finland.

DDX41, SAMD9L, ETV6, IKZF1, SRP72, FANCA, TERT, TERC, DKC1, NF1, CEBPA, SBDS, PAX5, GATA2, CDKN2A, NBN, ATM, CBL, MAP2K2, RIT1 , (...)

View the complete list with 19 more genes
Specificity
3 %
Genes
25 %
Comprehensive Hereditary Cancer Panel.

By Blueprint Genetics in Finland.

REST, PPM1D, EXO1, CD70, CEP57, ERCC1, MLH3, DDB2, DIS3L2, NTHL1, HOXB13, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, DDX41, SAMD9L , (...)

View the complete list with 126 more genes
Specificity
2 %
Genes
50 %
Hereditary Lung Cancer Panel.

By Blueprint Genetics in Finland.

EGFR, CDKN2A, TP53, BRCA2
Specificity
25 %
Genes
25 %
Hereditary Pancreatic Cancer Panel.

By Blueprint Genetics in Finland.

BUB1B, NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, FANCC, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
25 %
Comprehensive Hematology Panel.

By Blueprint Genetics in Finland.

ARPC1B, MRTFA, GINS1, DCLRE1B, ERCC6L2, MTHFD1, AP3D1, SMARCD2, WDR1, LMAN1, MCFD2, RPS29, MECOM, TMPRSS6, F13B, SERPINC1, DHFR, F13A1, TF, F12 , (...)

View the complete list with 219 more genes
Specificity
1 %
Genes
25 %
Bone Marrow Failure Syndrome Panel.

By Blueprint Genetics in Finland.

ERCC6L2, SMARCD2, RPS29, DDX41, SAMD9L, SAMD9, DNAJC21, PGM3, ACD, JAGN1, WIPF1, CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, VPS45, G6PC3, RPL15, ITK , (...)

View the complete list with 102 more genes
Specificity
1 %
Genes
25 %
Hereditary Gastrointestinal Cancer Panel.

By Blueprint Genetics in Finland.

NTHL1, RHBDF2, BUB1B, AXIN2, POLE, PDGFRA, GREM1, POLD1, KIT, SMARCB1, NF1, SMAD4, BMPR1A, SDHD, CDKN2A, STK11, CDH1, PALB2, ATM, TSC1 , (...)

View the complete list with 19 more genes
Specificity
3 %
Genes
25 %
Hereditary Breast and Gynecological Cancer Panel.

By Blueprint Genetics in Finland.

DICER1, XRCC2, FANCM, SMARCA4, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, BLM, TP53, PTEN , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
25 %
Hereditary Melanoma and Skin Cancer Panel.

By Blueprint Genetics in Finland.

DDB2, XPC, XPA, ERCC5, WRN, POT1, ERCC4, BAP1, MITF, ERCC3, ERCC2, CDKN2A, CDK4, SUFU, PTCH1, TP53, PTEN, BRCA2, BRCA1
Specificity
11 %
Genes
50 %
Hereditary Breast Cancer High Risk Panel.

By Blueprint Genetics in Finland.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Anemia Panel.

By Blueprint Genetics in Finland.

RPS29, TMPRSS6, DHFR, TF, REN, DNAJC21, LPIN2, C15orf41, GSS, TPI1, RHAG, EPB42, ANK1, SPTA1, SPTB, RPL15, SLC4A1, RPS7, ERCC4, XRCC2 , (...)

View the complete list with 58 more genes
Specificity
2 %
Genes
25 %
Hereditary Cancer High Risk Panel.

By Blueprint Genetics in Finland.

POLE, POLD1, BAP1, RAD51D, RAD51C, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
25 %
Limb Malformations Panel.

By Blueprint Genetics in Finland.

DLL4, BHLHA9, EOGT, TBX3, GDF5, RBPJ, DOCK6, ARHGAP31, SF3B4, WNT7A, ESCO2, RBM8A, ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
25 %
Hereditary Pancreatic Cancer Core Panel.

By Blueprint Genetics in Finland.

CDKN2A, STK11, PALB2, BRCA2, BRCA1
Specificity
20 %
Genes
25 %
BRCATRUE™.

By Pathway Genomics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BreastTrue.

By Pathway Genomics in United States.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
BRCAtrue Ashkenazi Jewish.

By Pathway Genomics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA 1 and BRCA2 Gene Sequencing.

By Genomic Research Center Shahid Beheshti University of Medical Sciences in Iran.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Focus::BRCA™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Focus::HERSite® NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, ATM, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Hereditary breast�¢����ovarian cancer syndrome type 2.

By Bioarray in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Breast Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

RAD54B, ESR2, ESR1, RAC1, ERBB4, ERBB2, KDR, CDK6, PIK3R1, AKT1, FBXW7, IDH1, EGFR, PIK3CA, FANCA, KIT, ERBB3, GATA3, FGFR1, BRIP1 , (...)

View the complete list with 22 more genes
Specificity
3 %
Genes
25 %
Genitourinary Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

PBRM1, CDKN1A, KMT2C, RXRA, ERBB2, PIK3R1, AKT1, AKT3, FBXW7, STAG2, EGFR, AKT2, PIK3CA, BAP1, ERBB3, TERT, KDM6A, MTOR, MED12, ERCC2 , (...)

View the complete list with 24 more genes
Specificity
3 %
Genes
25 %
Head & Neck Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

RHOA, BCL2L1, PIK3C2B, MCL1, KMT2C, NFE2L2, RAC1, FAT1, AFF3, ERBB2, CCND1, NOTCH2, PIK3R1, AKT1, AKT3, FBXW7, EGFR, AKT2, PIK3CA, GATA4 , (...)

View the complete list with 21 more genes
Specificity
3 %
Genes
25 %
BRCA ashkenazi.

By Laboratorio de Patologia Integral y Diagnostico Oportuno Laboratorio de Patologia Integral y Diagnostico Oportuno in Mexico.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary breast and ovarian cancer risk.

By Genomic Engenharia Molecular in Brazil.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Exome.

By DNA CONSULT GENETICA E BIOTECNOLOGIA LTDA. in Brazil.

IPW, SMNDC1, GEMIN2, HERC2, ATXN8, CYP2C9, IL1RN, CCDC88C, VKORC1, CYP2D6, CYP2C19, F8, F9, MAGEL2, SOX9, RPL10, PTCHD1, SEMA3E, SHANK2, KCND3 , (...)

View the complete list with 46 more genes
Specificity
2 %
Genes
25 %
BRCA1 and BRCA2 Sequencing.

By ApolloGen, Inc. in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast Cancer Panel.

By ApolloGen, Inc. in United States.

RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MLH1, MSH6, MSH2, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
iGene Cancer Panel.

By ApolloGen, Inc. in United States.

NF1, RAD51C, BRIP1, SMAD4, BMPR1A, CDKN2A, STK11, CDH1, PALB2, PTCH1, NBN, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
Genetic Test of single known genetic variant.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

GNAS, PKD1, PKD2, TSC1, TSC2, MEN1, RET, TP53, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Hereditary Breast and Ovarian Cancer BRCA1&2.

By GeneKor MSA in Greece.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Pancreatic Cancer (BRCA2, PALB2).

By GeneKor MSA in Greece.

PALB2, BRCA2
Specificity
50 %
Genes
25 %
BRCA1 and BRCA2 gene analysis.

By Veritas Genetics Veritas Genetics in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Breast and Ovarian Cancer 26 Gene Panel.

By Veritas Genetics Veritas Genetics in United States.

ABRAXAS1, XRCC2, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, MEN1, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
BRCA 1 and BRCA2 Gene Sequencing.

By Center for Comprehensive Genetic Services Shahid Beheshti University of Medical Sciences in Iran.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA Panel.

By Castle Medical Molecular Diagnostics Castle Medical, LLC in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA1/2 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
BRCA2 Mutation & Del/Dup Analysis.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary Cancer Comprehensive Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TP53BP1, KLLN, CHEK1, GEN1, MYH15, MYH1, MYH13, MYH4, PPM1D, HOXB13, MYH10, GALNT12, RAD51, AKT1, POLE, ABRAXAS1, ETV6, GREM1, POLD1, PIK3CA , (...)

View the complete list with 53 more genes
Specificity
2 %
Genes
25 %
Inherited Bone Marrow Failure Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TERF1, TERF2, DDX41, POT1, TERF2IP, ACD, GFI1, RPL26, G6PC3, RPL15, ELANE, CSF3R, ETV6, RPS7, THPO, SRP72, ERCC4, XRCC2, FANCD2, FANCI , (...)

View the complete list with 38 more genes
Specificity
2 %
Genes
25 %
BRCA2.

By Caris Life Sciences in United States.

BRCA2
Specificity
100 %
Genes
25 %
Hereditary Cancer.

By Color Genomics, Inc. Color Genomics, Inc. in United States.

POLE, GREM1, POLD1, BAP1, MITF, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
25 %
BRCA Test.

By Color Genomics, Inc. Color Genomics, Inc. in United States.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Otogenetics Hereditary Cancers.

By Otogenetics in United States.

PALLD, RAD51, NF1, NTRK1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2, PTCH1, NBN , (...)

View the complete list with 19 more genes
Specificity
3 %
Genes
25 %
FANCONI ANEMIA: NGS PANEL.

By Laboratorio de Genetica Clinica SL in Spain.

UBE2T, ERCC4, XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
6 %
Genes
25 %
PROSTATE CANCER.

By Laboratorio de Genetica Clinica SL in Spain.

CHEK2, BRCA2
Specificity
50 %
Genes
25 %
BREAST AND OVARIAN CANCER.

By Laboratorio de Genetica Clinica SL in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and Ovarian Hereditary Cancer, Deletions-Duplications (MLPA) BRCA2 Gene.

By Reference Laboratory Genetics in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Fanconi Anemia , Panel Massive Sequencing (NGS) 15 Genes.

By Reference Laboratory Genetics in Spain.

XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA, FANCB, RAD51C, BRIP1, PALB2, FANCC, BRCA2
Specificity
7 %
Genes
25 %
Breast and Ovarian Hereditary Cancer, Sequencing BRCA2 Gene.

By Reference Laboratory Genetics in Spain.

BRCA2
Specificity
100 %
Genes
25 %
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 90 Genes.

By Reference Laboratory Genetics in Spain.

CEP57, DDB2, DIS3L2, XPC, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL , (...)

View the complete list with 70 more genes
Specificity
3 %
Genes
50 %
Breast and Ovarian Hereditary Cancer , Panel Massive Sequencing (NGS) 20 Genes.

By Reference Laboratory Genetics in Spain.

NF1, RAD51D, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
5 %
Genes
25 %
Breast and Ovarian Hereditary Cancer , Panel Massive Sequencing and Deletions-Duplications(NGS) BRCA1 and BRCA2 Genes.

By Reference Laboratory Genetics in Spain.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Breast and Ovarian Hereditary Cancer , Panel Massive Sequencing (NGS) BRCA1,BRCA2,TP53,PALB2 Genes.

By Reference Laboratory Genetics in Spain.

PALB2, TP53, BRCA2, BRCA1
Specificity
25 %
Genes
25 %
Bone Marrow Failure Related Disorders , Panel Massive Sequencing (NGS) 59 Genes.

By Reference Laboratory Genetics in Spain.

CXCR4, RAC2, LAMTOR2, GFI1, RBM8A, RPL26, G6PC3, ELANE, CSF3R, JAK2, RAB27A, USB1, RPS7, SRP72, ERCC4, FANCD2, FANCI, FANCL, SLX4, FANCE , (...)

View the complete list with 38 more genes
Specificity
2 %
Genes
25 %
Familial Pancreatic Cancer , Panel Massive Sequencing (NGS) 16 Genes.

By Reference Laboratory Genetics in Spain.

MLH3, TGFBR2, SMAD4, CDKN2A, STK11, PALB2, KRAS, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Cutaneous Malignant Melanoma , Panel Massive Sequencing (NGS) 10 Genes.

By Reference Laboratory Genetics in Spain.

BAP1, TERT, MITF, CDKN2A, CDK4, MC1R, RB1, TP53, PTEN, BRCA2
Specificity
10 %
Genes
25 %
Glioma (Susceptibility to Somatic) , Panel Massive Sequencing (NGS) 12 Genes.

By Reference Laboratory Genetics in Spain.

ERBB2, IDH1, EGFR, PIK3CA, LGI1, BRAF, PRKN, IDH2, RB1, TP53, PTEN, BRCA2
Specificity
9 %
Genes
25 %
Familial Prostate Cancer , Panel Massive Sequencing (NGS) 11 Genes.

By Reference Laboratory Genetics in Spain.

MSR1, CHEK2, CDH1, NBN, AR, ZFHX3, RNASEL, ELAC2, EPCAM, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
Familial cancer of breast.

By Labor Dr. Wisplinghoff in Germany.

CHEK2, PALB2, BRCA2, BRCA1
Specificity
25 %
Genes
25 %
genTrue.

By True Health Diagnostics in United States.

POLE, POLD1, RAD51D, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, MUTYH, MLH1, MSH6 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
25 %
Phosphorus Breast Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

NF1, RAD51D, BARD1, RAD51C, BRIP1, CHEK2, STK11, CDH1, PALB2, NBN, ATM, TP53, PTEN, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Phosphorus Leukemia including Fanconi Anemia Genes Panel.

By Phosphorus Diagnostics LLC in United States.

ERCC4, XRCC2, FANCD2, FANCI, FANCL, FANCM, SLX4, FANCE, FANCF, FANCG, FANCA, TERT, TERC, DKC1, FANCB, NF1, RAD51C, CEBPA, GATA2, BRIP1 , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
25 %
Phosphorus Ovarian/Uterine Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, SMARCA4, RAD51D, RAD51C, BRIP1, PALB2, TP53, PTEN, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
7 %
Genes
25 %
Phosphorus Melanoma Panel.

By Phosphorus Diagnostics LLC in United States.

POT1, BAP1, MITF, CDKN2A, CDK4, RB1, TP53, PTEN, BRCA2
Specificity
12 %
Genes
25 %
Phosphorus Pancreatic Cancer including Chronic Pancreatitis Genes Panel.

By Phosphorus Diagnostics LLC in United States.

CTRC, PRSS1, SPINK1, CASR, NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, CFTR, MEN1, TP53, MLH1, MSH6, PMS2, MSH2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
Phosphorus Pancreatic Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

NF1, SMAD4, BMPR1A, CDKN2A, STK11, PALB2, ATM, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
5 %
Genes
25 %
Phosphorus Prostate Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

HOXB13, RAD51D, CHEK2, NBN, ATM, TP53, MLH1, MSH6, PMS2, MSH2, EPCAM, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Phosphorus Pan-Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AIP, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, XRCC2, KIT, SMARCB1, SMARCA4, SMARCE1, TERT , (...)

View the complete list with 63 more genes
Specificity
3 %
Genes
50 %
Phosphorus Common/High Risk Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

POLE, GREM1, POLD1, BAP1, MITF, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM , (...)

View the complete list with 12 more genes
Specificity
4 %
Genes
25 %
Breast and Ovarian Cancer: Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

XRCC2, SMARCA4, RAD51D, BARD1, RAD51C, BRIP1, RAD50, CHEK2, STK11, CDH1, PALB2, NBN, MRE11, ATM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
5 %
Genes
25 %
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RAD51B, EHBP1, POU6F2, EPHB2, MSMB, ASCC1, MSR1, XRCC3, PTCH2, PALLD, MLH3, DDB2, DIS3L2, MTAP, POLH, UROD, TMC8, TMC6, PDE11A, XPC , (...)

View the complete list with 123 more genes
Specificity
3 %
Genes
75 %
CEN4GEN Breast cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WEE1, ACVR1B, PTGFR, ZBED4, ZNF226, TRAF5, PPM1L, MAP2K4, PCGF2, PBRM1, FBXO32, EXOC2, NCOR1, MUC16, ESR1, KMT2C, ITCH, MYC, CBFB, ERBB2 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
25 %
Gastrointestinal and Colorectal Cancer: gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2, MSH2, APC, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Gastrointestinal and Colorectal Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

POLD1, SMAD4, BMPR1A, CHEK2, CDKN2A, STK11, CDH1, ATM, BLM, TP53, PTEN, MUTYH, MLH1, MSH6, MSH2, EPCAM, APC, BRCA2, BRCA1
Specificity
6 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
High Risk Breast Cancer: Gene Sequencing and Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

STK11, CDH1, PALB2, TP53, PTEN, BRCA2, BRCA1
Specificity
15 %
Genes
25 %
Melanoma: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WRN, BAP1, KIT, CDKN2A, CDK4, NRAS, BRAF, RB1, TP53, PTEN, BRCA2
Specificity
10 %
Genes
25 %
Pancreatic Cancer: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PRSS1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, MSH2, EPCAM, APC, VHL, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Pancreatic Cancer: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

PRSS1, CDKN2A, STK11, PALB2, ATM, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL, BRCA2, BRCA1
Specificity
8 %
Genes
25 %
Prostate cancer: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

CHEK2, NBN, TP53, BRCA2, BRCA1
Specificity
20 %
Genes
25 %
Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Cancer Syndrome: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
4 %
Genes
50 %
Hereditary Cancer Syndrome: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
4 %
Genes
50 %
BRCA mutation.

By Genomic Laboratory Semmelweis University in Hungary.

BRCA2, BRCA1
Specificity
50 %
Genes
25 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
25 %
Hereditary Brain, CNS, PNS Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, MRE11, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
25 %
VistaSeq Brain/CNS/PNS Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

SMARCB1, NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, MEN1, RB1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
25 %
Hereditary Cancer Panel - Neuro17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

NF1, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
25 %
BrainTumorNext.

By Ambry Genetics in United States.

DICER1, POT1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, CDKN2A, SUFU, NF2, PHOX2B, PTCH1, NBN, ALK, TSC1, TSC2, MEN1, TP53 , (...)

View the complete list with 7 more genes
Specificity
4 %
Genes
25 %
SUFU. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

SUFU
Specificity
100 %
Genes
25 %
Hereditary Brain Tumor Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

SMARCB1, SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
6 %
Genes
25 %
Medulloblastoma, desmoplastic (sequence analysis of SUFU gene).

By CGC Genetics in Portugal.

SUFU
Specificity
100 %
Genes
25 %
Meningiomatosis/ Multiple Meningioma NGS Panel.

By Medical Genomics Laboratory Department of Genetics UAB in United States.

SMARCB1, SMARCE1, SUFU, NF2
Specificity
25 %
Genes
25 %
Medulloblastoma and Nevoid Basal Cell Carcinoma Syndrome/Gorlin Syndrome via SUFU Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

SUFU
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome Deletion/ Duplication panel.

By Connective Tissue Gene Tests in United States.

PTCH2, SUFU, PTCH1
Specificity
67 %
Genes
50 %
Basal cell nevus syndrome Comprehensive panel.

By Connective Tissue Gene Tests in United States.

PTCH2, SUFU, PTCH1
Specificity
67 %
Genes
50 %
Basal cell nevus syndrome NGS panel.

By Connective Tissue Gene Tests in United States.

PTCH2, SUFU, PTCH1
Specificity
67 %
Genes
50 %
Joubert syndrome and related disorders NGS panel.

By Connective Tissue Gene Tests in United States.

ARMC9, PIBF1, ZNF423, CSPP1, PDE6D, KIF14, TMEM107, CEP120, CEP104, KIAA0556, C2CD3, TCTN3, B9D2, ARL13B, CPLANE1, CEP41, KIF7, RPGRIP1L, TCTN1, TCTN2 , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
Joubert syndrome and related disorders Deletion / Duplication panel.

By Connective Tissue Gene Tests in United States.

ARMC9, PIBF1, ZNF423, CSPP1, PDE6D, KIF14, TMEM107, CEP120, CEP104, KIAA0556, C2CD3, TCTN3, B9D2, ARL13B, CPLANE1, CEP41, KIF7, RPGRIP1L, TCTN1, TCTN2 , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
Joubert syndrome and related disorders Comprehensive panel.

By Connective Tissue Gene Tests in United States.

ARMC9, PIBF1, ZNF423, CSPP1, PDE6D, KIF14, TMEM107, CEP120, CEP104, KIAA0556, C2CD3, TCTN3, B9D2, ARL13B, CPLANE1, CEP41, KIF7, RPGRIP1L, TCTN1, TCTN2 , (...)

View the complete list with 17 more genes
Specificity
3 %
Genes
25 %
Basal cell nevus syndrome - SUFU Comprehensive test.

By Connective Tissue Gene Tests in United States.

SUFU
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome - SUFU NGS test.

By Connective Tissue Gene Tests in United States.

SUFU
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome - SUFU Deletion / Duplication test.

By Connective Tissue Gene Tests in United States.

SUFU
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome.

By Centogene AG - the Rare Disease Company in Germany.

SUFU
Specificity
100 %
Genes
25 %
Meningioma, familial, susceptibility to.

By Centogene AG - the Rare Disease Company in Germany.

SUFU
Specificity
100 %
Genes
25 %
Medulloblastoma, desmoplastic, familial.

By Centogene AG - the Rare Disease Company in Germany.

SUFU
Specificity
100 %
Genes
25 %
Single gene testing SUFU.

By CeGaT GmbH in Germany.

SUFU
Specificity
100 %
Genes
25 %
SUFU.

By Innovagenomics Innovagenomics S.L in Spain.

SUFU
Specificity
100 %
Genes
25 %
FAMILIAL MULTIPLE MENINGIOMA.

By Hereditary Cancer Group - Genetic Diagnostic Unit Germans Trias I Pujol Research Institute in Spain.

MN1, PDGFB, SMARCE1, SUFU, NF2, PTEN
Specificity
17 %
Genes
25 %
Invitae Sarcoma Panel.

By Invitae in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
25 %
Invitae Nervous System/Brain Cancer Panel.

By Invitae in United States.

DICER1, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, MEN1, RB1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
Invitae Pediatric Nervous System/Brain Tumors Panel.

By Invitae in United States.

DICER1, SMARCB1, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, MEN1, RB1, TP53, PTEN, MLH1, MSH6, PMS2 , (...)

View the complete list with 4 more genes
Specificity
5 %
Genes
25 %
Invitae Pediatric Solid Tumors Panel.

By Invitae in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, SMARCE1, NF1, CDC73, PRKAR1A, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C, STK11, SUFU, NF2 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
25 %
Invitae Basal Cell Nevus Syndrome Panel.

By Invitae in United States.

SUFU, PTCH1
Specificity
50 %
Genes
25 %
Meningioma, familial: SUFU gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

SUFU
Specificity
100 %
Genes
25 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
7 %
Genes
25 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
7 %
Genes
25 %
SUFU.

By Fulgent Genetics Fulgent Genetics in United States.

SUFU
Specificity
100 %
Genes
25 %
Nervous System / Brain Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, SUFU, NF2, PHOX2B, PTCH1, ATM, ALK, TSC1, TSC2, HRAS, MEN1, TP53, PTEN, MLH1, MSH6 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
Sarcoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, WRN, PDGFRA, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHA, SDHB, FH, SDHC, RB1, TP53, RECQL4 , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
25 %
Hereditary Pediatric Cancer Panel.

By Blueprint Genetics in Finland.

REST, DIS3L2, BUB1B, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, EZH2, RRAS, RASA2, NSUN2, LZTR1, NF1, CDC73, PRKAR1A, PRF1, CEBPA, PAX5 , (...)

View the complete list with 51 more genes
Specificity
2 %
Genes
25 %
Familial Meningioma , Sequencing SUFU Gene.

By Reference Laboratory Genetics in Spain.

SUFU
Specificity
100 %
Genes
25 %
Desmoplastic/Nodular Medulloblastoma , Sequencing SUFU Gene.

By Reference Laboratory Genetics in Spain.

SUFU
Specificity
100 %
Genes
25 %
Schwannomatosis, Panel Massive Sequencing (NGS) 7 Genes.

By Reference Laboratory Genetics in Spain.

PDGFB, SMARCB1, SMARCE1, LZTR1, SUFU, NF2, PTEN
Specificity
15 %
Genes
25 %
Hereditary Sarcoma (Susceptibility to) , Panel Massive Sequencing (NGS) 25 Genes.

By Reference Laboratory Genetics in Spain.

DICER1, WRN, KIT, NF1, PRKAR1A, SDHD, CDKN1C, SUFU, PTCH1, NBN, HRAS, BLM, SDHB, FH, SDHC, SDHAF2, RB1, TP53, RECQL4, MLH1 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
Basal Cell Nevus Syndrome , Panel Massive Sequencing (NGS) PTCH1, PTCH2, SUFU Genes.

By Reference Laboratory Genetics in Spain.

PTCH2, SUFU, PTCH1
Specificity
67 %
Genes
50 %
Familial Meningioma , Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

MN1, PDGFB, SMARCE1, SUFU, NF2, PTEN
Specificity
17 %
Genes
25 %
Phosphorus Brain and Nervous System Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, MAX, SDHD, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, SDHA, MEN1 , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
25 %
Phosphorus Pediatric Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, TERT, TERC, EZH2, NF1, CDC73, PRKAR1A, CEBPA, GATA2, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C , (...)

View the complete list with 33 more genes
Specificity
2 %
Genes
25 %
Brain, CNS, and PNS Cancer: Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, PMS2, MSH2, APC, VHL
Specificity
7 %
Genes
25 %
Brain, CNS, and PNS Cancer: Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PALB2, NF2, PHOX2B, PTCH1, NBN, ATM, ALK, MEN1, TP53, MLH1, MSH6, MSH2, APC, VHL
Specificity
7 %
Genes
25 %
Nevoid Basal Cell Carcinoma Syndrome: gene sequencing panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PTCH1
Specificity
50 %
Genes
25 %
Nevoid Basal Cell Carcinoma Syndrome: gene deletion/duplication.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SUFU, PTCH1
Specificity
50 %
Genes
25 %
Medulloblastoma (sequence analysis of PTCH2 gene).

By CGC Genetics in Portugal.

PTCH2
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome - PTCH2 NGS test.

By Connective Tissue Gene Tests in United States.

PTCH2
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome - PTCH2 Comprehensive test.

By Connective Tissue Gene Tests in United States.

PTCH2
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome - PTCH2 Deletion / Duplication test.

By Connective Tissue Gene Tests in United States.

PTCH2
Specificity
100 %
Genes
25 %
Basal cell nevus syndrome due to germline PTCH2 mutation.

By Centogene AG - the Rare Disease Company in Germany.

PTCH2
Specificity
100 %
Genes
25 %
Single gene testing PTCH2.

By CeGaT GmbH in Germany.

PTCH2
Specificity
100 %
Genes
25 %
PTCH2.

By Fulgent Genetics Fulgent Genetics in United States.

PTCH2
Specificity
100 %
Genes
25 %


If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PRIMARY PERITONEAL CARCINOMA HEMATURIA, BENIGN FAMILIAL; BFH DYSTONIA 3, TORSION, X-LINKED; DYT3 EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4 ALPHA-FETOPROTEIN, HEREDITARY PERSISTENCE OF; HPAFP GROWTH RETARDATION, DEVELOPMENTAL DELAY, AND FACIAL DYSMORPHISM; GDFD

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more